Comprehensive, Multimodal Characterization of an Imiquimod-Induced Human Skin Inflammation Model for Drug Development

Autor: Kolk, T. van der, Assil, S., Rijneveld, R., Klaassen, E.S., Feiss, G., Florencia, E., Prens, E.P., Burggraaf, J., Moerland, M., Rissmann, R., Doorn, M.B.A. van

Publikováno v: Clinical and Translational Science, 11(6), 607-615
Clinical and Translational Science
Clinical and Translational Science, 11(6), 607-615. Wiley-Blackwell Publishing Ltd

Imiquimod (IMQ) is often used as a topical challenge agent to provoke local skin inflammation. The objective of this study was to develop and refine a rapid, temporary, and reversible human skin inflammation model with IMQ for application in clinical

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::e3deb1513dbe22648dd704d7fd602bfe
http://hdl.handle.net/1887/86465

Antimicrobial Peptides: The Game-Changer in the Epic Battle Against Multidrug-Resistant Bacteria.

Autor: Hetta, Helal F.¹ (AUTHOR) hhussen@ut.edu.sa, Sirag, Nizar² (AUTHOR) nizarsirag@gmail.com, Alsharif, Shumukh M.¹ (AUTHOR) aam_alharbi@ut.edu.sa, Alharbi, Ahmad A.¹ (AUTHOR) talkendy@ut.edu.sa, Alkindy, Tala T.¹ (AUTHOR), Alkhamali, Alanoud³ (AUTHOR) aalkhamali@ut.edu.sa, Albalawi, Abdullah S.³ (AUTHOR) abs_albalawi@ut.edu.sa, Ramadan, Yasmin N.⁴ (AUTHOR) yasmine_mohamed@pharm.aun.edu.eg, Rashed, Zainab I.⁴ (AUTHOR) zeinab_rashed@pharm.aun.edu.eg, Alanazi, Fawaz E.⁵ (AUTHOR) sh_alsharef@ut.edu.sa

Publikováno v: Pharmaceuticals (14248247). Nov2024, Vol. 17 Issue 11, p1555. 30p.

Efficacy of Ceragenins in Controlling the Growth of Oral Microorganisms: Implications for Oral Hygiene Management.

Autor: Czarnowski, Michał¹ (AUTHOR) flaps.czarnowski@gmail.com, Słowińska, Monika¹ (AUTHOR) monika.slowinska@umb.edu.pl, Sawieljew, Mariusz¹ (AUTHOR) mariusz.sawieljew@umb.edu.pl, Wnorowska, Urszula¹ (AUTHOR) urszula.wnorowska@umb.edu.pl, Daniluk, Tamara¹ (AUTHOR) tamara.daniluk@umb.edu.pl, Król, Grzegorz² (AUTHOR) g.krol@op.pl, Karasiński, Maciej¹ (AUTHOR) maciek.karasinski@gmail.com, Okła, Sławomir^2,3 (AUTHOR) slawomir.okla@gmail.com, Savage, Paul B.⁴ (AUTHOR) pbsavage@chem.byu.edu, Piktel, Ewelina⁵ (AUTHOR) ewelina.piktel@umb.edu.pl, Bucki, Robert¹ (AUTHOR) buckirobert@gmail.com

Publikováno v: Pharmaceuticals (14248247). Feb2024, Vol. 17 Issue 2, p204. 17p.

Treatment with the Topical Antimicrobial Peptide Omiganan in Mild-to-Moderate Facial Seborrheic Dermatitis versus Ketoconazole and Placebo: Results of a Randomized Controlled Proof-of-Concept Trial.

Autor: Rousel, Jannik^1,2 (AUTHOR), Saghari, Mahdi^1,3 (AUTHOR), Pagan, Lisa^1,3 (AUTHOR), Nădăban, Andreea² (AUTHOR), Gambrah, Tom¹ (AUTHOR), Theelen, Bart⁴ (AUTHOR), de Kam, Marieke L.¹ (AUTHOR), Haakman, Jorine¹ (AUTHOR), van der Wall, Hein E. C.¹ (AUTHOR), Feiss, Gary L.⁵ (AUTHOR), Niemeyer-van der Kolk, Tessa¹ (AUTHOR), Burggraaf, Jacobus^1,2,3 (AUTHOR), Bouwstra, Joke A.² (AUTHOR), Rissmann, Robert^1,2,3 (AUTHOR) rrissmann@chdr.nl, van Doorn, Martijn B. A.^1,6 (AUTHOR)

Publikováno v: International Journal of Molecular Sciences. Sep2023, Vol. 24 Issue 18, p14315. 14p.

Antimicrobial Peptides in Infectious Diseases and Beyond—A Narrative Review.

Autor: Ioannou, Petros^1,2 (AUTHOR) p.ioannou@uoc.gr, Baliou, Stella² (AUTHOR), Kofteridis, Diamantis P.^1,2 (AUTHOR)

Publikováno v: Life (2075-1729). Aug2023, Vol. 13 Issue 8, p1651. 25p.